AtriCure
(NASDAQ) ATRC
AtriCure Financials at a Glance
Market Cap
$1.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$552.16M
Net Income (TTM)
-$4.59M
EPS (TTM)
-$0.10
P/E Ratio
-339.90
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$33.74
Volume
801,386.485
Open
$32.64
Price
$33.74
Volume
801,386.485
Open
$32.64
Previous Close
$33.66
Daily Range
$32.01 - $34.07
52-Week Range
$25.36 - $43.18
Estimated Earnings Date
Jul 23, 2026
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$33.74
Volume
801,386.485
Open
$32.64
Previous Close
$33.66
Daily Range
$32.01 - $34.07
52-Week Range
$25.36 - $43.18
Estimated Earnings Date
Jul 23, 2026
ATRC News
Why AtriCure, Inc. Shares Surged
Why AtriCure Inc. Shares Jumped
What to Expect from AtriCure
ATRC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AtriCure
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
1,350
CEO
Michael H. Carrel, MBA
Website
www.atricure.comHeadquarters
Mason, OH 45040, US
ATRC Financials
Key Financial Metrics (TTM)
Gross Margin
75.47%
Operating Margin
-0.36%
Net Income Margin
-0.83%
Return on Equity
-0.95%
Return on Capital
-0.59%
Return on Assets
-0.71%
Earnings Yield
-0.29%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
50.64M
Volume
801.39K
Avg. Volume
918.45K
Financials (TTM)
Gross Profit
$416.70M
Operating Income
-$1.97M
EBITDA
$24.70M
Operating Cash Flow
$64.36M
Capital Expenditure
-$10.72M
Free Cash Flow
$53.64M
Cash & ST Invst.
$146.17M
Total Debt
$74.91M
AtriCure Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$141.25M
+14.3%
Gross Profit
$109.31M
+18.0%
Gross Margin
77.39%
N/A
Market Cap
$1.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$1.28M
N/A
Employees
1,300
N/A
Net Income
$108.00K
+101.6%
EBITDA
$7.01M
+87687.5%
Quarterly Fundamentals
Total Cash
$146.17M
+46.3%
Total Debt
$74.91M
-3.2%
Accounts Receivable
$71.31M
+12.6%
Inventory
$81.14M
+8.3%
Long Term Debt
$71.78M
-3.7%
Short Term Debt
$3.13M
+10.2%
Return on Assets
-0.71%
N/A
Return on Invested Capital
-0.34%
N/A
Free Cash Flow
-$7.85M
+40.6%
Operating Cash Flow
-$4.00M
+63.8%